Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Marimed Inc banner

Marimed Inc
OTC:MRMD

Watchlist Manager
Marimed Inc Logo
Marimed Inc
OTC:MRMD
Watchlist
Price: 0.0878 USD -0.23% Market Closed
Market Cap: $34.7m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MRMD Price Targets Summary
Marimed Inc

Wall Street analysts forecast MRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRMD is 0.1683 USD with a low forecast of 0.0808 USD and a high forecast of 0.2625 USD.

MRMD Lowest Forecast
Wall Street Target
0.0808 USD
-8% Downside
MRMD Average Forecast
Wall Street Target
0.1683 USD
92% Upside
MRMD Highest Forecast
Wall Street Target
0.2625 USD
199% Upside
Lowest
Price Target
0.0808 USD
8% Downside
Average
Price Target
0.1683 USD
92% Upside
Highest
Price Target
0.2625 USD
199% Upside
Marimed Inc Competitors:
Price Targets

Revenue
Forecast

109% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
109% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 10 years the compound annual growth rate for Marimed Inc's revenue is 109%. The projected CAGR for the next 3 years is 4%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-45%
Average Miss
N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-45%
Average Miss

The compound annual growth rate of Marimed Inc's operating income for the next 3 years is 58%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat

What are analyst estimates?

See Also

Summary
MRMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRMD stock valuation using valuation multiples.
Wall Street Estimates
MRMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRMD's stock price target?
Price Target
0.1683 USD

According to Wall Street analysts, the average 1-year price target for MRMD is 0.1683 USD with a low forecast of 0.0808 USD and a high forecast of 0.2625 USD.

What is Marimed Inc's Revenue forecast?
Projected CAGR
4%

For the last 10 years the compound annual growth rate for Marimed Inc's revenue is 109%. The projected CAGR for the next 3 years is 4%.

What is Marimed Inc's Operating Income forecast?
Projected CAGR
58%

The compound annual growth rate of Marimed Inc's operating income for the next 3 years is 58%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.